ClinicalTrials.govpublic full text
Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer
borderline resectable pancreatic cancer, perioperative treatment, irinotecan liposome ii, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 890570
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.